Sodium ferulate glucose infusion liquid and its preparation method

A technology of sodium ferulate and glucose solution, applied in the field of medical infusion, can solve the problems of inability to guarantee the stability of sodium ferulate, low environmental cleanliness, inconvenient clinical medication, etc., and achieves remarkable curative effect, low cost and simple operation. Effect

Inactive Publication Date: 2006-05-10
ANHUI DOUBLE CRANE PHARMA
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] Sodium ferulate injection is clinically used in a large amount, but the injection is usually prepared by the hospital itself into a large-volume injection before use, which is not only inconvenient for clinical use, but also cannot guarantee the stability of the compatibility of sodium ferulate and the injection used sex
In addition, during the dilution and preparation process, if the operation is improper or the environment is not clean, it is also easy to be contaminated, which will cause pyrogenic reactions. Such situations are not uncommon in clinical practice.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0017] Add the weighed 4500mg of glucose into sterile water for injection and activated carbon for needles, boil, keep warm and stir to obtain a glucose solution, add 90mg of sodium ferulate and 10mg of calcium sodium edetate into the glucose solution, stir to dissolve, filter and add Sterile water for injection to the full amount, adjust the pH value to 4.0-6.0 with pH regulator sodium hydroxide, then finely filter, fill with nitrogen, fill in 500ml, 250ml, 100ml, 50ml infusion bottles, and sterilize by steam at 115°C After 30 minutes, the sodium ferulate glucose infusion was obtained.

Embodiment 2

[0019] Add 5000 mg of glucose weighed into sterile water for injection and activated carbon for needles, boil, heat and stir to obtain a glucose solution, add 100 mg of sodium ferulate and 20 mg of anhydrous sodium sulfite to the glucose solution, stir to dissolve, filter and add aseptic injection Water to the full amount, adjust the pH value to 4.0-6.0 with pH regulator sodium hydroxide, then finely filter, fill with nitrogen, fill and seal in 500ml, 250ml, 100ml, 50ml infusion bottles, and sterilize by steam at 115°C for 30 minutes. That is, sodium ferulate glucose infusion.

Embodiment 3

[0021] Add the weighed 5000mg of glucose into sterile water for injection and activated carbon for needles, boil, keep warm and stir to obtain a glucose solution, add 100mg of sodium ferulate and 10mg of sodium metabisulfite to the glucose solution, stir to dissolve, filter and add Sterile water for injection to the full amount, adjust the pH value to 4.0-6.0 with pH regulator sodium hydroxide, then finely filter, fill with nitrogen, fill in 500ml, 250ml, 100ml, 50ml infusion bottles, and sterilize by steam at 115°C After 30 minutes, the sodium ferulate glucose infusion was obtained.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to ferulae acid sodium glucose liquid and its producing method. It is characterized in that it is made from ferulae acid sodium (C10H9NaO4*2H2O), glucose and stabilizing agent, while the weight proportions are: ferulae acid sodium at 90-110mg, glucose at 4500-5500mg, and the stabilizing agent at 10-100mg, to be added with asepsis injection water to 100ml. The preparing method comprises: adding the glucose as said weight proportion into asepsis injection water and injection active carbon to be boiled and mixed with heat-insulation; then adding the ferulae acid sodium and stabilizing agent as said weight proportion to be mixed and dissolved; filtering and adding asepsis injection water to full content; adjusting the pH valve to 4.0-6.0; accurately filtering, charging nitrogen, sealing, and moist heat steam sterilizing at 115Deg. C for 30 minutes to attain the ferulae acid sodium glucose liquid. The invention has significant curative effect, better stability and litter bad effect, and it has simple operation, lower cost and wider drug source.

Description

technical field [0001] The invention relates to a medical transfusion, in particular to a sodium ferulate glucose transfusion and a preparation method thereof. technical background [0002] In the past century, human beings have made remarkable achievements in the fight against diseases, especially the prevention and treatment of cardiovascular diseases. According to statistics, in the past 30 years, due to the reduction of cardiovascular disease mortality, the life expectancy of Americans has been extended by 5 years. However, with the rapid growth of the population, the absolute number of causes of cardiovascular disease will still increase, and in developed countries, it is still the first cause of death. In 1997, the World Health Organization (WHO) announced the death statistics of various diseases in the world in 1996, showing that the number of deaths from coronary heart disease, stroke and other heart diseases reached 14 million, accounting for 28.8% of the total num...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/192A61K9/08A61K31/7004A61P9/10A61P25/04
Inventor 蔡春阳曹宗培何玲利
Owner ANHUI DOUBLE CRANE PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products